Lung Neoplasms

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Radiomics for Distinguishing Benign and Malignant Lung Nodules

HTL0039732 in Participants With Advanced Solid Tumours

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Low-Frequency rTMS for Sleep After Thoracoscopic Lung Resection

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)

SPSIPB vs SAPB for Thoracoscopic Surgery

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC

A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment

Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid Tumors

A Multicenter Cohort Study of AI-Based Methods for Pulmonary Nodule Diagnosis and Follow-up

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients

Family-centred Pulmonary Rehabilitation to Empower Carers

ERICA-02 Study : Impact of Physical Exercise on the Tumor Immune Microenvironment in Patients Treated With Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung Cancer

Multiparametric Lung MRI With Diffusion-Weighted Imaging in Lung-RADS 4 Lesion Characterization